Charles River Laboratories | Capitaux D'Emprunt



Loan Capital Changement Date
Agilent USD 3.35B 2M 2025-01
Align Technology USD 0 0 2024-12
Bio-Rad Laboratories USD 1.2B 338K 2024-12
Bruker USD 2.06B 202.7M 2024-12
Cardinal Health USD 7.06B 2.84B 2024-12
Charles River Laboratories USD 2.24B 86.45M 2024-12
Cigna USD 28.94B 1.29B 2024-12
CVS Health USD 60.53B 703M 2024-12
Danaher USD 15.5B 824M 2024-12
Dentsply International USD 1.59B 209M 2024-12
Elevance Health USD 29.22B 4.53B 2024-12
Galapagos EUR 8.24M 1000K 2024-12
Hologic USD 2.49B 19M 2024-12
Humana USD 11.14B 742M 2024-12
Illumina USD 1.49B 498M 2024-12
Incyte USD 33.54M 5.32M 2024-12
IQVIA Holdings USD 12.84B 545M 2024-12
Laboratory Of America USD 5.41B 21.8M 2024-12
Lonza CHF 4.24B 602M 2024-12
McKesson USD 4.42B 1.27B 2024-12
Merck EUR 6.37B 1.51B 2024-12
Mettler Toledo International USD 1.83B 60.4M 2024-12
Novartis USD 22.93B 2.41B 2024-12
Pfizer USD 57.4B 597M 2024-12
Quest Diagnostics USD 5.62B 33M 2024-12
Revvity USD 3.15B 35.22M 2024-12
Thermo Fisher Scientific USD 29.06B 2.14B 2024-12
United Therapeutics USD 0 0 2024-12
UnitedHealth USD 71.29B 1.07B 2025-03
Walgreens Boots Alliance USD 7.5B 1.02B 2025-02
Waters USD 1.63B 199.76M 2024-12
West Pharmaceutical Services USD 204.7M 100K 2024-12



Charles River Laboratories Capitaux D'Emprunt - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2025.